Report Detail
Global Q Fever Market Professional Survey Report 2019
- RnM3810308 |
- 09 October, 2019 |
- Global |
- 101 Pages |
- QYResearch |
- Chemical & Material
Q fever is a mild disease with flu-like symptoms. Many patients have no symptoms at all while in some cases; the infection can reoccur/resurface years later. The chronic Q fever is a more deadly form of Q fever which may damage heart, liver, brain, lungs and can cause diabetes in some cases.
The Americas account for the largest share in the global Q fever market owing to the presence of key players in the market and rising emphasis on diagnosis and treatment of rare diseases. Furthermore, the rising awareness about bacterial infection further accelerates the growth of the market. North America is the accounted for the highest market share in this region with the U.S. being the largest market followed by Canada. In the U.S, the prevalence of cardiovascular disease is found to be increasing from last few years. This is attributed to the rising prevalence of chronic diseases such as obesity and diabetes which are major risk factors for cardiovascular diseases.
The global Q Fever market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Q Fever volume and value at global level, regional level and company level. From a global perspective, this report represents overall Q Fever market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Q Fever in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Q Fever manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Yashica Pharmaceuticals Private Limited (India)
Merck & Co. (US)
Atox Bio (Israel)
Teva Pharmaceutical Industries (Israel)
Basilea Pharmaceutica Ltd. (Switzerland)
MELINTA THERAPEUTICS, INC. (US)
Pfizer (US)
Cipla Inc. (India)
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Acute Q Fever
Chronic Q Fever
Segment by Application
Hospitals & Clinics
Diagnostic Centers
Surgical Centers
Table of Contents
Executive Summary
1 Industry Overview of Q Fever
- 1.1 Definition of Q Fever
- 1.2 Q Fever Segment by Type
- 1.2.1 Global Q Fever Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Acute Q Fever
- 1.2.3 Chronic Q Fever
- 1.3 Q Fever Segment by Applications
- 1.3.1 Global Q Fever Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospitals & Clinics
- 1.3.3 Diagnostic Centers
- 1.3.4 Surgical Centers
- 1.4 Global Q Fever Overall Market
- 1.4.1 Global Q Fever Revenue (2014-2025)
- 1.4.2 Global Q Fever Production (2014-2025)
- 1.4.3 North America Q Fever Status and Prospect (2014-2025)
- 1.4.4 Europe Q Fever Status and Prospect (2014-2025)
- 1.4.5 China Q Fever Status and Prospect (2014-2025)
- 1.4.6 Japan Q Fever Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Q Fever Status and Prospect (2014-2025)
- 1.4.8 India Q Fever Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Q Fever
- 2.3 Manufacturing Process Analysis of Q Fever
- 2.4 Industry Chain Structure of Q Fever
3 Development and Manufacturing Plants Analysis of Q Fever
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Q Fever Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Q Fever
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Q Fever Production and Capacity Analysis
- 4.2 Q Fever Revenue Analysis
- 4.3 Q Fever Price Analysis
- 4.4 Market Concentration Degree
5 Q Fever Regional Market Analysis
- 5.1 Q Fever Production by Regions
- 5.1.1 Global Q Fever Production by Regions
- 5.1.2 Global Q Fever Revenue by Regions
- 5.2 Q Fever Consumption by Regions
- 5.3 North America Q Fever Market Analysis
- 5.3.1 North America Q Fever Production
- 5.3.2 North America Q Fever Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Q Fever Import and Export
- 5.4 Europe Q Fever Market Analysis
- 5.4.1 Europe Q Fever Production
- 5.4.2 Europe Q Fever Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Q Fever Import and Export
- 5.5 China Q Fever Market Analysis
- 5.5.1 China Q Fever Production
- 5.5.2 China Q Fever Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Q Fever Import and Export
- 5.6 Japan Q Fever Market Analysis
- 5.6.1 Japan Q Fever Production
- 5.6.2 Japan Q Fever Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Q Fever Import and Export
- 5.7 Southeast Asia Q Fever Market Analysis
- 5.7.1 Southeast Asia Q Fever Production
- 5.7.2 Southeast Asia Q Fever Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Q Fever Import and Export
- 5.8 India Q Fever Market Analysis
- 5.8.1 India Q Fever Production
- 5.8.2 India Q Fever Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Q Fever Import and Export
6 Q Fever Segment Market Analysis (by Type)
- 6.1 Global Q Fever Production by Type
- 6.2 Global Q Fever Revenue by Type
- 6.3 Q Fever Price by Type
7 Q Fever Segment Market Analysis (by Application)
- 7.1 Global Q Fever Consumption by Application
- 7.2 Global Q Fever Consumption Market Share by Application (2014-2019)
8 Q Fever Major Manufacturers Analysis
- 8.1 Yashica Pharmaceuticals Private Limited (India)
- 8.1.1 Yashica Pharmaceuticals Private Limited (India) Q Fever Production Sites and Area Served
- 8.1.2 Yashica Pharmaceuticals Private Limited (India) Product Introduction, Application and Specification
- 8.1.3 Yashica Pharmaceuticals Private Limited (India) Q Fever Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Merck & Co. (US)
- 8.2.1 Merck & Co. (US) Q Fever Production Sites and Area Served
- 8.2.2 Merck & Co. (US) Product Introduction, Application and Specification
- 8.2.3 Merck & Co. (US) Q Fever Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Atox Bio (Israel)
- 8.3.1 Atox Bio (Israel) Q Fever Production Sites and Area Served
- 8.3.2 Atox Bio (Israel) Product Introduction, Application and Specification
- 8.3.3 Atox Bio (Israel) Q Fever Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Teva Pharmaceutical Industries (Israel)
- 8.4.1 Teva Pharmaceutical Industries (Israel) Q Fever Production Sites and Area Served
- 8.4.2 Teva Pharmaceutical Industries (Israel) Product Introduction, Application and Specification
- 8.4.3 Teva Pharmaceutical Industries (Israel) Q Fever Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Basilea Pharmaceutica Ltd. (Switzerland)
- 8.5.1 Basilea Pharmaceutica Ltd. (Switzerland) Q Fever Production Sites and Area Served
- 8.5.2 Basilea Pharmaceutica Ltd. (Switzerland) Product Introduction, Application and Specification
- 8.5.3 Basilea Pharmaceutica Ltd. (Switzerland) Q Fever Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 MELINTA THERAPEUTICS, INC. (US)
- 8.6.1 MELINTA THERAPEUTICS, INC. (US) Q Fever Production Sites and Area Served
- 8.6.2 MELINTA THERAPEUTICS, INC. (US) Product Introduction, Application and Specification
- 8.6.3 MELINTA THERAPEUTICS, INC. (US) Q Fever Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Pfizer (US)
- 8.7.1 Pfizer (US) Q Fever Production Sites and Area Served
- 8.7.2 Pfizer (US) Product Introduction, Application and Specification
- 8.7.3 Pfizer (US) Q Fever Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Cipla Inc. (India)
- 8.8.1 Cipla Inc. (India) Q Fever Production Sites and Area Served
- 8.8.2 Cipla Inc. (India) Product Introduction, Application and Specification
- 8.8.3 Cipla Inc. (India) Q Fever Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Q Fever Market
- 9.1 Global Q Fever Market Trend Analysis
- 9.1.1 Global Q Fever Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Q Fever Regional Market Trend
- 9.2.1 North America Q Fever Forecast 2019-2025
- 9.2.2 Europe Q Fever Forecast 2019-2025
- 9.2.3 China Q Fever Forecast 2019-2025
- 9.2.4 Japan Q Fever Forecast 2019-2025
- 9.2.5 Southeast Asia Q Fever Forecast 2019-2025
- 9.2.6 India Q Fever Forecast 2019-2025
- 9.3 Q Fever Market Trend (Product Type)
- 9.4 Q Fever Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Q Fever Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Q Fever. Industry analysis & Market Report on Q Fever is a syndicated market report, published as Global Q Fever Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Q Fever market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
